日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Dechloromonas aromatica Shikimate kinase (aroK) CSB-YP671808DAAH
CSB-EP671808DAAH
CSB-BP671808DAAH
CSB-MP671808DAAH
CSB-EP671808DAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dechloromonas aromatica Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP671809DAAH
CSB-EP671809DAAH
CSB-BP671809DAAH
CSB-MP671809DAAH
CSB-EP671809DAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dechloromonas aromatica Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C (gatC) CSB-YP671810DAAH
CSB-EP671810DAAH
CSB-BP671810DAAH
CSB-MP671810DAAH
CSB-EP671810DAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca Putative membrane protein insertion efficiency factor (Tfu_3115) CSB-YP671811TAAF
CSB-EP671811TAAF
CSB-BP671811TAAF
CSB-MP671811TAAF
CSB-EP671811TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca Protein CrcB homolog 2 (crcB2), partial CSB-YP671812TAAF1
CSB-EP671812TAAF1
CSB-BP671812TAAF1
CSB-MP671812TAAF1
CSB-EP671812TAAF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca D-tyrosyl-tRNA (Tyr) deacylase (dtd) CSB-YP671813TAAF
CSB-EP671813TAAF
CSB-BP671813TAAF
CSB-MP671813TAAF
CSB-EP671813TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca Mycothiol acetyltransferase (mshD) CSB-YP671814TAAF
CSB-EP671814TAAF
CSB-BP671814TAAF
CSB-MP671814TAAF
CSB-EP671814TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca NADH-quinone oxidoreductase subunit H (nuoH), partial CSB-YP671815TAAF
CSB-EP671815TAAF
CSB-BP671815TAAF
CSB-MP671815TAAF
CSB-EP671815TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca UPF0336 protein Tfu_2666 (Tfu_2666) CSB-YP671816TAAF
CSB-EP671816TAAF
CSB-BP671816TAAF
CSB-MP671816TAAF
CSB-EP671816TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca DNA-directed RNA polymerase subunit beta' (rpoC), partial CSB-YP671817TAAF
CSB-EP671817TAAF
CSB-BP671817TAAF
CSB-MP671817TAAF
CSB-EP671817TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca 50S ribosomal protein L22 (rplV) CSB-YP671818TAAF
CSB-EP671818TAAF
CSB-BP671818TAAF
CSB-MP671818TAAF
CSB-EP671818TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca 30S ribosomal protein S14 type Z (rpsZ) CSB-YP671819TAAF
CSB-EP671819TAAF
CSB-BP671819TAAF
CSB-MP671819TAAF
CSB-EP671819TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca Adenylate kinase (adk) CSB-YP671820TAAF
CSB-EP671820TAAF
CSB-BP671820TAAF
CSB-MP671820TAAF
CSB-EP671820TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca 50S ribosomal protein L13 (rplM) CSB-YP671821TAAF
CSB-EP671821TAAF
CSB-BP671821TAAF
CSB-MP671821TAAF
CSB-EP671821TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca Bifunctional protein FolD (folD) CSB-YP671822TAAF
CSB-EP671822TAAF
CSB-BP671822TAAF
CSB-MP671822TAAF
CSB-EP671822TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca ATP synthase gamma chain (atpG) CSB-YP671823TAAF
CSB-EP671823TAAF
CSB-BP671823TAAF
CSB-MP671823TAAF
CSB-EP671823TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca Trigger factor (tig) CSB-YP671824TAAF
CSB-EP671824TAAF
CSB-BP671824TAAF
CSB-MP671824TAAF
CSB-EP671824TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca LexA repressor (lexA) CSB-YP671825TAAF
CSB-EP671825TAAF
CSB-BP671825TAAF
CSB-MP671825TAAF
CSB-EP671825TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca Aspartate--tRNA ligase (aspS), partial CSB-YP671826TAAF
CSB-EP671826TAAF
CSB-BP671826TAAF
CSB-MP671826TAAF
CSB-EP671826TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermobifida fusca Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP671827TAAF
CSB-EP671827TAAF
CSB-BP671827TAAF
CSB-MP671827TAAF
CSB-EP671827TAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×